Chumnith Peter Bour

Chumnith Peter Bour is a seasoned professional in pharmacovigilance, currently serving as a Senior Manager in Pharmacovigilance Operations at AbbVie, following their tenure at ImmunoGen, Inc. From 2009 to 2013, Chumnith built foundational expertise as a Drug Safety Associate at Genzyme and later as a Clinical Safety Associate at Harvard Clinical Research Institute. Over the years, Chumnith has held prominent roles at various companies, including Clovis Oncology, Lantheus Medical Imaging, and Boehringer Ingelheim, primarily focusing on the management and oversight of pharmacovigilance operations and vendor relations. Chumnith earned a Bachelor of Science in Pharmaceutical Sciences from the Massachusetts College of Pharmacy and Health Sciences in 2009.